Page results
-
Advice on socialising and managing friendships for young people living with fatigue syndromes.
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
Once again, UCLH has received the highest score of all general acute and acute/community NHS trusts in England for staff that would recommend us as a place to work
-
An online talk about being active. The talk is for people who have recently finished cancer treatment at UCLH
-
Here you find all of our information leaflets which will help with day to day diabetes management including managing highs and lows, sick day rules and managing school days including the most up to date school care plans. You will also find information on how to upload your devices at home.
-
Komal Khuti-Dullaart is one of more than 300,000 patients using MyCare UCLH, our app and online service to help manage patient care.
-
UCLH Phlebotomy department is introducing Swiftqueue - an appointment system that enables patients, and GPs who refer patients, to book UCLH blood test appointments online.
-
UCLH clinical trial practitioner Antonette Andrews was amazed to learn that her great aunt came to the UK as part of the Windrush Generation and joined the NHS, where Antonette works today.
-
An advertising campaign has launched in north London to encourage people to take up a free NHS lung health check, provided by UCLH. Campaign posters will be on a number of bus shelters in Barnet, Camden, Enfield, Haringey and Islington, selected underground stations and online until the end of November.
File results
-
FOI/2024/0148 - Cleaning audit system at Trust
-
FOI/2024/0149 - National Hospital for Neurology and Neurosurgery (NHNN) admissions 2018-2023
-
FOI/2024/0155 - Immunotherapy treatments for lung cancer
-
FOI/2024/0162 - Various technology systems/ services used at Trust
-
FOI/2024/0163 - Renal cell carcinoma and melanoma treatments
-
FOI/2024/0166 - Recruitment systems/CRM platform
-
FOI/2024/0171 - Dermatology consultants
-
FOI/2024/0172 - Patients excluded from care at the Trust 2010-2023
-
FOI/2024/0179 - Water usage/ procurement
-
FOI/2024/0183 - Immunology Hidradenitis Suppurativa (HS) treatment